|
黃冠穎等譯，2008，腸病毒71型的感染與防治，疫情報導371，台北
陳豪勇等譯，1999，最新醫學微生物學上冊，藝軒圖書出版社，台北
Ali B, Naima NA, Laila M, Rozenn R, Ahmed B, Didier G, Moncef N. (2010) “Purification and identification of novel antioxidant peptides from enzymatic hydrolysates of sardinelle (Sardinella aurita) byproducts proteins.” Food Chem, 118: 559–565.
Amadou I, Olasunkanmi S, Gbadamosi Shi YH, Kamara MT, Jin S, Le GW. (2010) “Identi-fication of antioxidative peptides from Lactobacillus plantarum Lp6 fermentedsoybean protein meal.” Res J Microbiol 5:372–80.
Anderson JW, Johnstone BM, Cook-Newell ME. (1995) “Meta-analysis of the effect ofsoy protein intake on serum lipids.” N Engl J Med 333:276–82.
Aoyama T, Fukui K, Nakamori T, Hashimoto Y, Yamamoto T, TakamatsuK. (2000) “Effect of soy and milk whey protein isolates and their hydrolysateson weight reduction in genetically obese mice.” Biosci Biotechnol Biochem 64:2594–600.
Ascencio C, Torres N, Isoard-Acosta F, Gomez-Perez FJ, Hernandez-Pando R, Tovar AR. (2004) “Soy protein affects serum insulin and hepatic SREBP-1 mRNA andreduces fatty liver in rats.” J Nutr 134:522–9.
Beermann C, Euler M, Herzberg J, Stahl B. (2009) “Anti-oxidative capacity of enzymat-ically released peptides from soybean protein isolate.” Eur Food Res Technol 229:637–44.
Brogden KA. (2005) “Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria.” Nature Reviews Microbiology 3: 238–250.
Brown DM, Kauder SE, Cornell CT, Jang GM, Racaniello VR, Semler BL. (2004) “Cell-dependent role for the poliovirus 3’ noncoding region in positive-strand RNA synthesis.” J Virol 78: 1344–51.
Buenz EJ, Howe CL. (2006) “Picornaviruses and cell death.” Trends Microbiol 14: 28–36.
Chen HM, Muramoto K, Yamauchi F, Fujimoto K, Nokihara K. (1998) “Antioxidativeproperties of histidine-containing peptides designed from peptide fragmentsfound in the digests of a soybean protein.” J Agric Food Chem 46:49–53.
Chen HM, Muramoto K, Yamauchi F. (1995) “Structural analysis of antioxidative pep-tides from soybean β-conglycinin.” J Agric Food Chem 43:574–8.
Cruz J, Ortiz C, Guzman F, Fernandez-Lafuente R, Torres R. (2014). “Antimicrobial peptides: promising compounds against pathogenic microorganisms.” Current Medicinal Chemistry 21: 2299–2321.
Dhananjay S, Kulkarni S, Kapanoor KG, Naganagouda VK, VeerappaHM. (2006) “Reduction of flatus-inducing factors in soymilk by immobilized-galactosidase.” Biotechnol Appl Biochem 45:51–7.
Donkor O, Henriksson A, Singh T, Vasiljevic T, Shah N. (2007) “ACE-inhibitory activityof probiotic yoghurt.” Int Dairy J 17:1321–31.
Egger D, Pasamontes L, Bolten R, Boyko V, Bienz K. (1996) “Reversible dissociation of the poliovirus replication complex: function and interactions of its components in viral RNA synthesis.” J Virol 70: 8675-83.
Emini EA, Jameson BA, Lewis AJ, Larsen GR, Wimmer E. (1982) “Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.” J Virol 43: 997-1005.
Fong TT, Lipp EK. (2005) “Enteric viruses of humans and animals in apuatic environments: health risks, detection, and potential water quality assessment tools.” Microbiol Mol Biol Rev 7: 357-71.
Fosgerau K., Hoffmann T. (2015). “Peptide therapeutics: current status and future directions.” Drug Discovery Today, 20: 122–128.
Fritz D, Venturi CR, Cargnin S, Schripsema J, Roehe PM, Montanha JA, et al. (2007) “Herpes virus inhibitory substances from Hypericum connatum Lam., a plant used in southern Brazil to treat oral lesions.” J Ethnopharmacol. 113:517–20.
Galvez AF, Revilleza MJR, Lumen BO. (1997) “A novel methionine-rich protein fromsoybean cotyledon: cloning and characterization of cDNA.” Plant Physiol 114:1567–9.
Halliwell B. (1994) “Free radicals, antioxidants, and human disease: curiosity, cause,or consequence.” Lancet 344:721–4.
Hernandez LB, Amigo L, Ramos M, Recio I. (2004) “Angiotensin converting enzymeinhibitory activity in commercial fermented products. Formation of pep-tides under simulated gastrointestinal digestion.” J Agric Food Chem 52:1504–10.
Hori G, Wang MF, Chan YC, Komatsu T, Wong Y, Chen TH. (2001) “Soy proteinhydrolyzate with bound phospholipids reduces serum cholesterol levelsin hypercholesterolemic adult male volunteers.” Biosci Biotechnol Biochem 65:72–8.
Ho M, Chen ER, Hsu KH. (2000) “An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.” N Engl J Med 341: 929–35.
Hsiung GD, Wang JR. (2000) “Enterovirus infections with special reference to enterovirus 71.” J Microbiol Immunol Infect 33: 1–8.
Hsieh C, Blanca H, Lumen B. (2010) “Soybean peptide lunasin suppresses in vitro andin-vivo 7,12-dimethylbenz[a]anthracene-induced tumorigenesis.” J Food Sci 75:311–6.
Hwang JS, Yoo HJ, Song HJ. (2011) “Inflammation-related signaling pathways impli-cating TGF are revealed in the expression profiling of MCF7 cell treated withfermented soybean, Chungkookjang.” Nutr Cancer 63:645–52.
Iritani N, Nagashima K, Fukuda H, Katsurada A, Tanaka T. (1986) “Effects of dietaryproteins on lipogenic enzymes in rat liver.” J Nutr 116: 190–7.
Ishimaru Y, Nakano S, Yamaoka K, Takami S. (1980) “Outbreaks of hand, foot, and mouth disease by enterovirus 71: High incidence of complication disorders of central nervous system.” Arch Dis Child 55: 583-8.
Kitts DD, Weiler K. (2003) “Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery.” Current Pharmaceutical Design 9: 1309–1323.
Kobayashi M, Hirahata R, Egusa S, Fukuda M. (2012) “Hypocholesterolemic effects oflactic acid-fermented soymilk on rats fed a high cholesterol diet.” Nutrients 4: 1304–16.
Pimenta AMC, De Lima ME. (2005). “Small peptides, big world: biotechnological potential in neglected bioactive peptides from arthropod venoms.” Journal of Peptide Science 11: 670–676.
Kono R. (1975) “Apollo 11 disease or acute hemorrhagic conjunctivitis: a pandemic of a new enterovirus infection of the eyes.” Am J Epidemiol 101: 383-90.
Kuba M, Tanaka K, Tawata S, Takeda Y, Yasuda M. (2003) “Angiotensin I convert-ing enzyme inhibitory peptides isolated from fermented soybean food.” BiosciBiotechnol Biochem 67: 1278–83.
Kwon DY, Oh SW, Lee JS, Yang HJ, Lee SH, Lee JH. (2002) “Amino acid substitution ofhypocholesterolemic peptide originated from glycinin hydrolyzate.” Food SciBiotechnol 11: 55–61.
Lam Y, Galvez AF, de Lumen BO. (2003) “Lunasin suppresses E1A-mediated transfor-mation of mammalian cells but does not inhibit growth of immortalized andestablished cancer cell lines.” Nutr Cancer 47: 88–94.
Li Y, Yu J. (2015) “Research progress in structure-activity relationship of bioactive peptides.” Journal of Medicinal Food 18: 147–156.
Liu JR, Wang SY, Lin YY, Lin CW. (2002) “Antitumor activity of milk kefir and soy milkkefir in tumor-bearing mice.” Nutr Cancer 44: 183–7.
Lu J, Zeng Y, Hou W, Zhang S, Li L, Luo X, Xi W, Chen Z, Xiang M. (2012) “The soybeanpeptide aglycin regulates glucose homeostasis in type 2 diabetic mice viaIR/IRS1 pathway.” J Nutr Biochem 23: 1449–57.
Lumen BO. (2005) “Lunasin: a cancer-preventive soy peptide.” Nutr Rev 63: 16–21.
McLean DM, Larke RP, Mcnaughton GA, Smith P. (1964) “Enteroviral syndromes in Toronto.” Can Med Assoc J 92: 658-61.
Mercier A, Gauthier SF, Fliss I. (2004) “Immunomodulating effects of whey proteinsand their enzymatic digests.” Int Dairy J 14: 175–83.
Mejia EG, Dia VP. (2009) “Lunasin and lunasin-like peptides inhibit inflamma-tion through suppression of NFkB pathway in the macrophage.” Peptides 30: 2388–98.
Moran TH. (2000) “Cholecystokinin and satiety: current perspectives.” Nutrition 16: 858–65.
Paul AV, Boom JH, Filippov D, Wimmer E. (1998) “Protein-primed RNA synthesis by purified poliovirus RNA polymerase.” Nature 393: 280-4.
Pietiäinen VM, Marjomäki V, Heino JT. (2005) “Viral entry, lipid rafts and caveosomes.” Ann Med 37: 394-403.
Potter SM. (1995) “Overview of proposed mechanisms for the hypocholesterolemiceffect of soy.” J Nutr 125: 606.
Pommer K. (1995) “New proteolytic enzymes for the production of savory ingredients.”
Rayaprolu SJ, Hettiarachchy NS, Chen P, Kannan A, Mauromostakos A. (2013) “Peptides derived from high oleic acid soybean meals inhibit colon, liver and lungcancer cell growth.” Food Res Int 50:282–8.
Rho SJ, Lee JS, Chung Y, Kim YM, Lee HG. (2009) “Purification and identification of anangiotensin I-converting enzyme inhibitory peptide from fermented soybeanextract.” Process Biochem 44: 490–3.
Ruekert RR, Fields BN, Knipe DM, Howley PM. (1996) “Picornaviridae: The Viruses and Their Replication, third ed., Fields Virology Lippincott-Raven Publishers.” Philadelphia 609-640.
Sagara M, Kanda T, Njelekera M, Teramoto T, Armitage L, Birt N, Birt C, YamoriY. (2004) “Effects of dietary intake of soy protein and isoflavones on cardiovasculardisease risk factors in high risk, middle-aged men in Scotland.” J Am Coll Nutr 23: 85–91.
Schmidt NJ, Lenette EH, Ho HH. (1974) “An apparently new wnterovirus isolates from patients with disease of the central nervous system.” J Infect Dis 129: 304-9.
Seppo L, Jauhiainen T, Poussa T, Korpela RA. (2003) “Fermented milk high in bioactivepeptides has a blood pressure lowering effect in hypertensive subjects.” Am J Clin Nutr 77: 326–30.
Shimakage A, Shinbo M, Yamada S. (2012) “ACE inhibitory substances derived fromsoy foods.” J Biol Macromol 12: 72–80.
Staljanssens D, Camp JV, Billiet A, Meyer T, Shukor N, Vos WH, Smagghe G. (2012) “Screening of soy and milk protein hydrolysates for their ability to activate theCCK1 receptor.” Peptides 34: 226–31.
Sugano M, Goto S, Yamada Y, Yoshida K, Hashimoto Y, Matsuo T, KimotoM. (1990) “Cholesterol-lowering activity of various undigested fractions of soybeanprotein in rats.” J Nutr 120: 977–85.
Takenaka Y, Utsumi S, Yoshikawa M. (2000) “Introduction of enterstatin (VPDPR) anda related sequence into soybean proglycinin A1aB1b subunit by site-directedmutagenesis.” Biosci Biotechnol Biochem 64: 2731–3
Todorov SD, Wachsman MB, Knoetze H, Meincken M, Dicks LM.(2005) “An antibacterial and antiviral peptide produced by Enterococcus mundtii ST4V isolated from soya beans.” International Journal of Antimicrobial Agents 25:508–513.
Greaves KA, Wilson MD, Rudel LL, Williams JK, Wagner JD. (2000) “Consumption of soy protein reduces cholesterol absorption compared to casein protein aloneor supplemented with an isoflavone extract or conjugated equine estrogen inovariectomized cynomolgous monkeys.” J Nutr 130: 820–6.
Thomas MB, Martin JJR, Rosalia CMS, Frank AS. (2005) “Soy protein isolate and pro-tection against cancer.” J Am Coll Nutr 24: 146–9.
Wang SM, Liu CC, Tseng HW, Wang JR, Huang CC, Chen YJ, Yang YJ, Lin SJ, Yeh TF. (1999) “Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications.” Clin Infect Dis 29: 184-90.
Wu J, Ding H. (2001) “Hypotensive and physiological effect of angiotensin convert-ing enzyme inhibitory peptides derived from soy protein on spontaneouslyhypertensive rats.” J Agric Food Chem 49: 501–6.
Yan JJ, Wang JR, Liu CC, Yang HB, Su IJ. (2000) “An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis.” J Clin Virol 17: 13-22.
Yang JH, Mau JL, Ko PT, Huang LC. (2000) “Antioxidant properties of fermented soy-bean broth.” Food Chem 71: 249–54.
Yoshikawa M, Fujita H, Matoba N, Takenaka Y, Yamamoto T, Yamauchi R, Tsu-ruki H, Takahata K. (2000) “Bioactive peptides derived from food proteins preventinglifestyle-related diseases.” BioFactors 12: 143–6.
Zhong F, Liu J, Ma J, Shoemaker C. (2007) “Preparation of hypocholesterol peptidesfrom soy protein and their hypocholesterolemic effect in mice.” Food Res Int 40: 661–7.
|